MICHELLE CAMASTRO: Open Payments
NPI 1356727747 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 13 payments from 7 companies in 2025. Trend: 2023 $442 · 2024 $574 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $96 |
| Lilly USA, LLC | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: Wegovy, MOUNJARO, CAPLYTA, SPRAVATO, Auvelity, FREESTYLE LIBRE 3, CONTRAVE.
Industry payments across NY — which companies pay providers there.
